TAG ARCHIVES FOR Blog Squad

25
Aug2021

As hospitals have become essential treatment centers for COVID-19 patients, clinical trial participants have become increasingly averse to attending check-ups and monitoring visits at these sites. Telemedicine is now being recognized not only as an option for those who do not have convenient access to healthcare, but also as a means by which clinical trials can be accomplished. Read more

8
Jul2021

Before I joined the IRB administration team, I thought IRB reviewers were members of a secret society whose sole purpose was to strike down research. Like others before me, I believed my research would be put on the IRB butcher’s block and be chopped into little bits. However, IRB administrators want to see quality research out in the field and will work tirelessly to help guide researchers towards compliance to reach that goal. Read more

11
Jun2021

The COVID-19 pandemic has brought to light, once again, the ongoing issue of racial health inequalities in the United States and around the globe. As the first vaccines and treatments for COVID-19 were being approved for use around the world, scrutiny of medical research and its oversight has highlighted the fact that there is still much to do to resolve the unending epidemic of racism in healthcare and to ensure diversity in clinical trials. Read more

5
May2021

On March 5, 2020, I recall a phone conversation with the chairperson of the IRB. I said, "so, what is this COVID thing?" Famous last words, one might suggest. Despite my naivete of the virus in those early days, we still had to support researchers with swift, precise responses. To compensate for gaps in knowledge, we formed a Research Compliance & Safety Committee. Read more